
    
      This study will be composed by 2 groups of 103 participants, patients undergoing cardiac
      surgery and needing oral anticoagulation in the early postoperative period.

      The control group will receive vitamin K antagonist and the study group will receive direct
      oral anticoagulant. The investigators will call back each participants at 3 months to report
      the ischemic and bleeding complications during this period and evaluated the quality of life
      of the oral anticoagulation.
    
  